By David Sachs Merck KGaA said that it has partnered with BenevolentAI and Exscientia on an initiative to discover more drugs with artificial intelligence,.
The U.S.-listed shares of Exscientia PLC soared 28.5% toward a record one-day gain, and enough to pace all premarket gainers on major U.S. exchanges, after.
By Michael Susin Physiomics has been awarded a further contract with German health-care and technology company Merck KGaA, the company said Thursday. The.